...
首页> 外文期刊>Biochimica et biophysica acta. Molecular cell research >Signaling components of the 1α,25(OH)2D3-dependent Pdia3 receptor complex are required for Wnt5a calcium-dependent signaling
【24h】

Signaling components of the 1α,25(OH)2D3-dependent Pdia3 receptor complex are required for Wnt5a calcium-dependent signaling

机译:Wnt5a钙依赖性信号传导需要1α,25(OH)2D3依赖性Pdia3受体复合物的信号传导成分

获取原文
获取原文并翻译 | 示例

摘要

Wnt5a and 1α,25(OH)2D3 are important regulators of endochondral ossification. In osteoblasts and growth plate chondrocytes, 1α,25(OH)2D3 initiates rapid effects via its membrane-associated receptor protein disulfide isomerase A3 (Pdia3) in caveolae, activating phospholipase A2 (PLA2)-activating protein (PLAA), calcium/calmodulin-dependent protein kinase II (CaMKII), and PLA2, resulting in protein kinase C (PKC) activation. Wnt5a initiates its calcium-dependent effects via intracellular calcium release, activating PKC and CaMKII. We investigated the requirement for components of the Pdia3 receptor complex in Wnt5a calcium-dependent signaling. We determined that Wnt5a signals through a CaMKII/PLA2/PGE2/PKC cascade. Silencing or blocking Pdia3, PLAA, or vitamin D receptor (VDR), and inhibition of calmodulin (CaM), CaMKII, or PLA2 inhibited Wnt5a-induced PKC activity. Wnt5a activated PKC in caveolin-1-silenced cells, but methyl-beta-cyclodextrin reduced its stimulatory effect. 1α,25(OH)2D3 reduced stimulatory effects of Wnt5a on PKC in a dose-dependent manner. In contrast, Wnt5a had a biphasic effect on 1α,25(OH)2D3-stimulated PKC activation; 50ng/ml Wnt5a caused a 2-fold increase in 1α,25(OH)2D3-stimulated PKC but higher Wnt5a concentrations reduced 1α,25(OH)2D3-stimulated PKC activation. Western blots showed that Wnt receptors Frizzled2 (FZD2) and Frizzled5 (FZD5), and receptor tyrosine kinase-like orphan receptor 2 (ROR2) were localized to caveolae. Blocking ROR2, but not FZD2 or FZD5, abolished the stimulatory effects of 1α,25(OH)2D3 on PKC and CaMKII. 1α,25(OH)2D3 membrane receptor complex components (Pdia3, PLAA, caveolin-1, CaM) interacted with Wnt5a receptors/co-receptors (ROR2, FZD2, FZD5) in immunoprecipitation studies, interactions that changed with either 1α,25(OH)2D3 or Wnt5a treatment. This study demonstrates that 1α,25(OH)2D3 and Wnt5a mediate their effects via similar receptor components and suggests that these pathways may interact.
机译:Wnt5a和1α,25(OH)2D3是软骨内骨化的重要调节剂。在成骨细胞和生长板软骨细胞中,1α,25(OH)2D3通过其膜相关受体蛋白二硫键异构酶A3(Pdia3)在小窝中启动快速作用,激活磷脂酶A2(PLA2)激活蛋白(PLAA),钙/钙调蛋白-依赖性蛋白激酶II(CaMKII)和PLA2,导致蛋白激酶C(PKC)激活。 Wnt5a通过细胞内钙释放,激活PKC和CaMKII来启动其钙依赖性作用。我们调查了Wnt5a钙依赖性信号传导中Pdia3受体复合物成分的需求。我们确定Wnt5a信号通过CaMKII / PLA2 / PGE2 / PKC级联。沉默或阻断Pdia3,PLAA或维生素D受体(VDR),并抑制钙调蛋白(CaM),CaMKII或PLA2可抑制Wnt5a诱导的PKC活性。 Wnt5a激活了Caveolin-1沉默的细胞中的PKC,但甲基β-环糊精降低了其刺激作用。 1α,25(OH)2D3以剂量依赖的方式降低了Wnt5a对PKC的刺激作用。相比之下,Wnt5a对1α,25(OH)2D3刺激的PKC激活具有双相作用。 50ng / ml Wnt5a导致1α,25(OH)2D3刺激的PKC增加2倍,但更高的Wnt5a浓度降低1α,25(OH)2D3刺激的PKC激活。 Western印迹显示Wnt受体Frizzled2(FZD2)和Frizzled5(FZD5),以及酪氨酸激酶样孤儿受体2(ROR2)定位于小窝。阻止ROR2,但不阻止FZD2或FZD5,取消了1α,25(OH)2D3对PKC和CaMKII的刺激作用。在免疫沉淀研究中,1α,25(OH)2D3膜受体复合物组分(Pdia3,PLA,caveolin-1,CaM)与Wnt5a受体/共受体(ROR2,FZD2,FZD5)相互作用,相互作用随1α,25( OH)2D3或Wnt5a处理。这项研究表明1α,25(OH)2D3和Wnt5a通过相似的受体成分介导其作用,并暗示这些途径可能相互作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号